Orchid Pharma Limited is a vertically integrated pharmaceutical company based in Chennai, India, founded in 1992 by Kailasam Raghavendra Rao. The company is recognized as a global leader in cephalosporins and anti-infectives, operating across the entire pharmaceutical value chain from drug discovery to delivery. Orchid Pharma ranks among the top pharmaceutical companies in India and exports to over 50 countries, with a significant portion of its exports going to regulated markets. The company offers a wide range of pharmaceutical services, including the manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms, as well as contract research and manufacturing services. Orchid Pharma has a diverse product portfolio, with strengths in cephalosporin APIs, anti-infectives, and new chemical entities, including Enmetazobactam, which is the only new chemical entity discovered by an Indian pharmaceutical company. With USFDA-compliant facilities and a commitment to high-quality standards, Orchid Pharma is dedicated to providing responsible and accessible healthcare solutions globally.